Furthermore, identifying dysregulated ALDH3A1 expression in OSCC cells will help us better understand tumor progression and metastasis, and suggest a possible therapeutic strategy for oral cancer. This evidence concerns the gene ALDH3A1 and lip and oral cavity carcinoma.